SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001554795-24-000045
Filing Date
2024-03-12
Accepted
2024-03-12 14:23:59
Documents
14
Period of Report
2023-11-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A cncl0312form8ka1.htm   iXBRL 8-K/A 26492
  Complete submission text file 0001554795-24-000045.txt   200839

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cncl-20231130.xsd EX-101.SCH 3049
3 XBRL LABEL FILE cncl-20231130_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cncl-20231130_pre.xml EX-101.PRE 22343
16 EXTRACTED XBRL INSTANCE DOCUMENT cncl0312form8ka1_htm.xml XML 3723
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-32363 | Film No.: 24741543
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)